Poor correlation between published methods to predict creatinine clearance and measured creatinine clearance in asymptomatic HIV infected individuals

Renal Failure

Volumn 20, Issue 4, 1998, Pages 627-633

  Noormohamed, Saleem E ^a   Katseres, Julie K ^b   Stapleton, Jack T ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Creatinine clearance; HIV; HIV infection; Out patient

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; CREATININE; PLASMA PROTEIN; SERUM ALBUMIN; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG CLEARANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; MALE; OUTPATIENT CARE; PREDICTION; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 0031823328     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045156     Document Type: Article

References (17)

1. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976.
2. Hull JH, Hak LJ, Koch CG, Wargin WA, Chi SL, Mattox AM: Influence of range of renal function and liver disease on predictability of creatinine clearance. Clini Pharmacol Ther 29:516-521, 1981.
3. Jelliffe RW, Jelliffe SM: A computer program for estimating creatinine clearance from unstable serum creatinine concentrations. Math and Biosci 14:17-24, 1972.
4. Mawer GE, Lucas SB, Knowles BR, Stirland RM: Computer assisted prescribing of kanamycin for patients with renal insufficiency. Lancet 1:12-15, 1972.
5. Schwartz GJ, Haycock GB, Edelmaun CM, Jr., Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatr 58:259-263, 1976.
6. Wagner JG: Fundamental of Clinical Pharmacokinetics. Drug Intelligence Publications, Hamilton, IL, 1975, p 162.
7. Rao TK: A decade of human immunodeficiency virus associated nephropathy (HIVAN). Transplantation Proceedings 25:2439-2440, 1993.
8. Patton NI, MacCallan DC, Jebb SA, Noble C, Baldwin C, Pazina SM, Griffin GE: Longitudinal changes in body composition measured with variety of methods in patients with AIDS. J AID & Hum Retorvirol 14:119-127, 1997.
9. Jelliffe RW: Creatinine clearance: bedside estimate. Ann Intern Med 79:604-605, 1973.
10. Sheiner LB, Beal SL, Sheiner LB: Some suggestions for measuring predictive performance. J Pharm and Biopharamceut 9:503-512, 1981.
11. Jaffe M: J Physiological Chem 10:313, 1986.
12. Iwata I, Nishikazo O: New micro-turbidimetric method of determination of protein in cerebrospinal fluid and urine. Clini Chem 25:1317-1319, 1979.
13. Luxton R, Patel P, Keir G, Thompson E: A micromethod for measuring total protein in cerebrospinal fluid by using benzethonium chloride in microtiter plate wells. Clini Chem 35:1731-1734, 1989.
14. Haycock GB, Schwartz GJ, Wisotsky DH: Geometric method of measuring body surface area: a height-weight formula validated in infants, children and adults. J Pediatr 93:62-66, 1978.
15. Devine B: Gentamicin therapy. DICP 8:650-655, 1974.
16. Smith BL, Sarnoski TP, Dennis S, Luke DR: Failure of predicted creatinine clearance equations in HIV-seropositive patients. International J Clini Pharmacol Ther Toxicol 33:394-399, 1992.
17. Huang E, Hewitt RG, Shelton M, Morse GD: Comparison of measured and estimated creatinine clearance in patients with HIV disease. Pharmacotherapy 16:222-220, 1996.